From first episode to long-term care: The need for sustained clinical commitment

Area of Science:

• Psychiatry and Mental Health
• Clinical Psychology
• Neuroscience

Background:

• Many patients face significant delays in accessing treatment for severe mental illness after symptom onset and social disability.
• Delayed treatment negatively impacts patients, families, and long-term prognosis.
• Early and comprehensive assessment by experienced clinicians is vital for optimal patient outcomes.

Purpose of the Study:

• To emphasize the importance of prompt clinical assessment for severe mental illness.
• To highlight the primary objectives of early-stage schizophrenia treatment: symptom improvement and functional recovery.
• To address challenges in treatment, including partial response, resistance, relapse, and comorbid depression.

Main Methods:

• Review of evidence on treatment access and outcomes in severe mental illness.
• Discussion of clinical principles for early-stage intervention in schizophrenia.
• Consideration of both objective symptoms and subjective patient experience in treatment assessment.

Main Results:

• Despite optimal treatment, many schizophrenia patients experience persistent symptoms and functional impairment, indicating partial response or resistance.
• Relapse is a common and serious issue, influenced by antipsychotic treatment adherence and depressive symptoms.
• Depressive symptoms are prevalent and increase the risk of relapse in schizophrenia patients.

Conclusions:

• Treatment objectives may require modification based on response patterns, relapse cycles, or depressive symptoms.
• Sustained clinical commitment is essential for all patients, particularly those with complex treatment needs.
• Addressing subjective patient experience alongside objective symptoms is crucial for effective antipsychotic treatment assessment.